Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer
NCT00445406Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Dec 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00445406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445406.